BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 18084917)

  • 21. Virtual high-throughput screening of molecular databases.
    Seifert MH; Kraus J; Kramer B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries.
    Ma XH; Jia J; Zhu F; Xue Y; Li ZR; Chen YZ
    Comb Chem High Throughput Screen; 2009 May; 12(4):344-57. PubMed ID: 19442064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine.
    Lin Y; Zhang Y; Wang D; Yang B; Shen YQ
    Phytomedicine; 2022 Dec; 107():154481. PubMed ID: 36215788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtual screening in drug discovery -- a computational perspective.
    Reddy AS; Pati SP; Kumar PP; Pradeep HN; Sastry GN
    Curr Protein Pept Sci; 2007 Aug; 8(4):329-51. PubMed ID: 17696867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of Novel Drug-like Molecules Using Informatics Rich Secondary Metabolites Analysis of Indian Medicinal and Aromatic Plants.
    Karade D; Vijayasarathi D; Kadoo N; Vyas R; Ingle PK; Karthikeyan M
    Comb Chem High Throughput Screen; 2020; 23(10):1113-1131. PubMed ID: 32504496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scopy: an integrated negative design python library for desirable HTS/VS database design.
    Yang ZY; Yang ZJ; Lu AP; Hou TJ; Cao DS
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32892221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virtual screening: are we there yet?
    Jalaie M; Shanmugasundaram V
    Mini Rev Med Chem; 2006 Oct; 6(10):1159-67. PubMed ID: 17073716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to Prepare a Compound Collection Prior to Virtual Screening.
    Bologa CG; Ursu O; Oprea TI
    Methods Mol Biol; 2019; 1939():119-138. PubMed ID: 30848459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural product hybrids as new leads for drug discovery.
    Tietze LF; Bell HP; Chandrasekhar S
    Angew Chem Int Ed Engl; 2003 Sep; 42(34):3996-4028. PubMed ID: 12973759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reverse Pharmacognosy and Reverse Pharmacology; Two Closely Related Approaches for Drug Discovery Development.
    Saeidnia S; Gohari AR; Manayi A
    Curr Pharm Biotechnol; 2016; 17(11):1016-22. PubMed ID: 27396403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual screening - what does it give us?
    Köppen H
    Curr Opin Drug Discov Devel; 2009 May; 12(3):397-407. PubMed ID: 19396741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modern methods to produce natural-product libraries.
    Abel U; Koch C; Speitling M; Hansske FG
    Curr Opin Chem Biol; 2002 Aug; 6(4):453-8. PubMed ID: 12133720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Libraries from natural product-like scaffolds.
    Boldi AM
    Curr Opin Chem Biol; 2004 Jun; 8(3):281-6. PubMed ID: 15183326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMR-based screening methods for lead discovery.
    Vogtherr M; Fiebig K
    EXS; 2003; (93):183-202. PubMed ID: 12613177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example.
    Rollinger JM; Haupt S; Stuppner H; Langer T
    J Chem Inf Comput Sci; 2004; 44(2):480-8. PubMed ID: 15032527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural product-like synthetic libraries.
    Thomas GL; Johannes CW
    Curr Opin Chem Biol; 2011 Aug; 15(4):516-22. PubMed ID: 21684804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.